Enorama Financial Statements From 2010 to 2024
| ERMA Stock | SEK 3.77 0.09 2.33% |
Check Enorama Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enorama Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Enorama financial statements analysis is a perfect complement when working with Enorama Pharma Valuation or Volatility modules.
Enorama |
Enorama Pharma AB Company Current Valuation Analysis
Enorama Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Enorama Pharma Current Valuation | 42.1 M |
Most of Enorama Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enorama Pharma AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Enorama Pharma AB has a Current Valuation of 42.1 M. This is 99.71% lower than that of the Healthcare sector and 99.43% lower than that of the Drug Manufacturers - Specialty & Generic industry. The current valuation for all Sweden stocks is 99.75% higher than that of the company.
Enorama Pharma AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enorama Pharma's current stock value. Our valuation model uses many indicators to compare Enorama Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enorama Pharma competition to find correlations between indicators driving Enorama Pharma's intrinsic value. More Info.Enorama Pharma AB is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enorama Pharma's earnings, one of the primary drivers of an investment's value.About Enorama Pharma Financial Statements
Enorama Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Enorama Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Enorama Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Enorama Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Enorama Pharma AB , a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. Enorama Pharma AB is a subsidiary of Swede Unipharma AB. Enorama Pharma is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Enorama Stock Analysis
When running Enorama Pharma's price analysis, check to measure Enorama Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enorama Pharma is operating at the current time. Most of Enorama Pharma's value examination focuses on studying past and present price action to predict the probability of Enorama Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enorama Pharma's price. Additionally, you may evaluate how the addition of Enorama Pharma to your portfolios can decrease your overall portfolio volatility.